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Cardio(lipin) workout beefs up mitochondrial imports
Mitochondria depend on imported proteins. Kutik et al. show how a protein keeps this molecular 
traffi  c fl  owing by helping manufacture a key membrane lipid.
Almost all of the 1,000 or so different proteins mitochondria need to operate are made elsewhere in 
the cell. After crossing a mitochondrion’s outer membrane, proteins follow one of two routes through the 
organelle’s inner membrane. In the carrier pathway, the protein complex TIM22 shepherds molecules into 
the inner membrane. The presequence pathway, by contrast, relies on the TIM23 complex. Researchers 
recently discovered that a protein called Tam41 was required for TIM23 to effi  ciently import presequence 
molecules. Whether Tam41 also helped out in the carrier pathway was controversial.
Kutik et al. used yeast devoid of Tam41 to answer the question. The researchers measured 
whether carrier-transported proteins combined into complexes, a sign that they’d arrived at their 
destination. The team found that in the mutant cells, the proteins often reached the inner membrane 
but didn’t assemble into mature complexes. And the electrical potential that usually exists across the 
inner membrane dwindled. Those results suggest that not only is the presequence pathway faulty 
when Tam41 is missing, so is the carrier pathway.
The mitochondrial defects resembled those caused by a scarcity of cardiolipin, an inner 
membrane lipid. Cardiolipin performs many jobs in mitochondria, including stabilizing the protein 
complexes involved in electron transport. Cardiolipin was almost absent from the mutant cells. Tam41 
does not synthesize cardiolipin directly, but helps to fashion one of its precursors, the team found. 
Next task, the researchers say, is to identify that step.
Kutik, S., et al. 2008. J. Cell Biol. doi:10.1083/jcb.200806048.
DNA, just chill
To keep transcribing, the genes that encode ribosomal RNA (rRNA) need to remain relaxed. Sanij et 
al. reveal how a transcription-promoting protein prevents these genes from getting uptight.
Human cells have rRNA genes aplenty—roughly 200 of them, which are arranged in clusters. 
Tuning their output is crucial because too little rRNA can stifl  e cell growth, whereas too much might 
lead to cancer. A factor that controls rRNA production is the protein UBF. It maintains rRNA genes in 
a loose conformation that allows transcription, rather than a condensed and inactive state. How UBF 
achieved this feat was an unanswered question.
To fi nd out more, Sanij et al. used RNAi to trim UBF levels in human cells by 80%. The researchers’ 
analysis ruled out one method that cells often employ to shut down genes permanently—affi  xing methyl 
groups. In fact, the team showed, rRNA silencing is reversible, unlike methylation. The researchers 
think that UBF works by obstructing the H1 linker histone, which helps stabilize nucleosome particles 
and allows them to condense into higher-order structures. The linker histone’s effect is to compact the 
DNA, thereby silencing genes. But when UBF is present, the histone can’t gain access to the DNA.
The study’s big surprise came when the researchers measured rRNA output in cells with scant 
UBF. Instead of plunging, rRNA levels remained constant. The cells compensated by cranking up the 
activity of the genes that remained turned on. Cells could muster suffi  cient rRNA even with 90% of 
the genes shut down. This result indicates that UBF’s actions serve another purpose besides adjusting 
rRNA levels, such as stabilizing DNA.
Sanij, E., et al. 2008. J. Cell Biol. doi:10.1083/jcb.200805146.
Without cardiolipin—made with the 
help of Tam41—transport of proteins 
into mitochondria like these falters.
Glowing clusters of UBF mark rRNA genes.
More insulin-positive cells (brown) 
occur in mice lacking leptin-making fat 
cells (left) than in control mice (right).
Leptin’s long-distance call to the pancreas
Rube Goldberg—the cartoonist who devised complex machines for simple tasks—would have smiled 
at one of leptin’s mechanisms for curbing insulin release. As Hinoi et al. show, the fat-derived 
hormone enlists the sympathetic nervous system to prevent bone-making cells from releasing a 
molecule that prods the pancreas to discharge insulin.
In the fi  ght against obesity and diabetes, leptin is one of the good guys. Mice lacking the 
hormone become corpulent, and their sky-high insulin levels eventually lead to diabetes. Leptin can 
curtail insulin release directly. But there’s also a back-door route that researchers are still trying to 
piece together. Scientists knew that leptin nudges osteoblasts, cells known for building bone but that 
also manufacture osteocalcin, a protein that stimulates insulin release. Hinoi et al. tested whether 
leptin acts on the pancreas through osteocalcin.
Leptin channels many of its effects through the nervous system. The team thus tested whether 